← Deal Flow

CTIBIOTECH USA

Deep
1Rounds
0Articles
General InformationCTIBIOTECH USA appears to be a biotechnology company focused on cellular or tissue engineering solutions, though specific details about employee count and founding date could not be verified through available search results.
Funding & FinancialsNo confirmed funding information, stage, or investor details were found in accessible sources for this company.
Leadership & TeamLeadership and team composition details for CTIBIOTECH USA could not be confirmed from available public sources.
Recent ActivityRecent activities, product launches, or partnerships for CTIBIOTECH USA could not be identified through current web searches.

Highlights

Total Raised
1 rounds
Latest Round
$27
May 10, 2026
Stage
deep-tech
Employees
Headquarters
News Coverage
Talent Signals
SEC Filings

Funding History

$27
2026
Strategic
SEC Form D   Editorial
May 10, 2026
$27 millionStrategic · Editorial

<cite index="11-3,11-4">CTIBIOTECH, a pioneering 3D bioprinting organization and global leader in human tissue bioprinting, announced the launch of its North American subsidiary to provide proprietary human cell and tissue bioassays and New Approach Methods to North American pharmaceutical and biomedical markets.</cite>

Similar Companies 6